1
00:00:00,000 --> 00:00:02,120
Speaker 1: It looks like the drug that made oprah skinny is

2
00:00:02,120 --> 00:00:04,320
Speaker 1: going to be available in New Zealand. Shortly put this

3
00:00:04,400 --> 00:00:08,360
Speaker 1: in your diary. First of July. Next Tuesday, we go

4
00:00:08,480 --> 00:00:11,559
Speaker 1: V also known as ozempic, as going to be available,

5
00:00:11,560 --> 00:00:13,560
Speaker 1: but you will still need a prescription from your doctor.

6
00:00:13,840 --> 00:00:17,440
Speaker 1: Doctor Arna Spencon is the vice president Medical Oceania at

7
00:00:17,480 --> 00:00:20,000
Speaker 1: Novo Nordes because this is a company that makes Osempic

8
00:00:20,040 --> 00:00:23,840
Speaker 1: and is with us. Now Anna, hello, Hello, is Tuesday

9
00:00:23,880 --> 00:00:25,160
Speaker 1: the big day?

10
00:00:26,280 --> 00:00:28,400
Speaker 2: Of course, it is a big day because it's very

11
00:00:28,440 --> 00:00:31,960
Speaker 2: important for us to being something that two point eight

12
00:00:32,000 --> 00:00:35,479
Speaker 2: million people in New Zealand may need. So it is

13
00:00:35,520 --> 00:00:37,800
Speaker 2: a major advancement for them. And these are the people

14
00:00:37,840 --> 00:00:41,600
Speaker 2: who are leaving the overweight and obesity and you need

15
00:00:41,640 --> 00:00:44,280
Speaker 2: to be able to get to their healthy wait and

16
00:00:44,360 --> 00:00:45,520
Speaker 2: maintain their healthy way.

17
00:00:45,960 --> 00:00:47,800
Speaker 1: Okay, Can I just just make sure that you are

18
00:00:47,840 --> 00:00:50,159
Speaker 1: confirming it's happening on Tuesday, because up to now we've

19
00:00:50,200 --> 00:00:52,360
Speaker 1: had no official confirmation that I can see.

20
00:00:52,520 --> 00:00:57,280
Speaker 2: Since Tuesday, Sylvia sayings from first of July will be available.

21
00:00:57,440 --> 00:00:58,920
Speaker 1: Okay, how much is it going to cost?

22
00:01:01,040 --> 00:01:05,080
Speaker 2: The cost will be absolutely similar to what Saxander is

23
00:01:05,120 --> 00:01:09,120
Speaker 2: in New Zealand. So approximately five hundred dollars New Zealand dollars,

24
00:01:09,160 --> 00:01:11,240
Speaker 2: of course, and that's how.

25
00:01:11,160 --> 00:01:14,000
Speaker 1: We put get and that's for a month, is it?

26
00:01:15,040 --> 00:01:15,400
Speaker 2: Yes?

27
00:01:15,680 --> 00:01:18,120
Speaker 1: Okay, how much demand do you think there is going

28
00:01:18,160 --> 00:01:19,160
Speaker 1: to be in New Zealand?

29
00:01:20,840 --> 00:01:22,760
Speaker 2: Well, I won't be able to tell you how much

30
00:01:22,800 --> 00:01:25,280
Speaker 2: demand will be that I can tell you how many

31
00:01:25,360 --> 00:01:28,880
Speaker 2: people in New Zealand lived in obesity? Is they set

32
00:01:28,880 --> 00:01:33,119
Speaker 2: two point eight million people or individuals living with obesity

33
00:01:33,120 --> 00:01:35,800
Speaker 2: in over eight and also we know that some of

34
00:01:35,840 --> 00:01:38,959
Speaker 2: them one hundred and seventy thousands of people are also

35
00:01:39,000 --> 00:01:43,040
Speaker 2: suffering from established cardiovascar disease. So what would be the

36
00:01:43,080 --> 00:01:47,319
Speaker 2: demand is difficult. The clinicians would need to see patients

37
00:01:47,360 --> 00:01:49,280
Speaker 2: and decide on the eligibis.

38
00:01:49,200 --> 00:01:52,280
Speaker 1: I mean, of course it's one thing to need it,

39
00:01:52,280 --> 00:01:53,800
Speaker 1: it's another to be able to afford it. Is it

40
00:01:53,800 --> 00:01:54,600
Speaker 1: publicly funded?

41
00:01:56,040 --> 00:01:59,880
Speaker 2: It's not public's hundred is yet it will be available

42
00:02:00,080 --> 00:02:02,280
Speaker 2: to you know, the patient can get the script from

43
00:02:02,320 --> 00:02:06,840
Speaker 2: their clinicians. We as a company, we are determined to

44
00:02:06,880 --> 00:02:10,320
Speaker 2: work with a government of Haarmak and see whether whether

45
00:02:10,360 --> 00:02:14,640
Speaker 2: we can get that rainburst for those that are eligible

46
00:02:15,040 --> 00:02:15,960
Speaker 2: but not yet.

47
00:02:16,480 --> 00:02:20,160
Speaker 1: Okay, so what of the criticism though that there are

48
00:02:20,160 --> 00:02:22,639
Speaker 1: people who legitimately need this, you know, to be able

49
00:02:22,680 --> 00:02:25,160
Speaker 1: to manage their diabetes rather than just get their skinny

50
00:02:25,200 --> 00:02:27,480
Speaker 1: on and that they're going to they're going to potentially

51
00:02:27,480 --> 00:02:29,399
Speaker 1: lose out because everybody is going to try to get

52
00:02:29,440 --> 00:02:29,959
Speaker 1: slim off it.

53
00:02:30,320 --> 00:02:35,440
Speaker 2: What do you say to that, Look, this, this product

54
00:02:35,480 --> 00:02:40,160
Speaker 2: with Goovi that's indicated for chronic rate management is something

55
00:02:40,200 --> 00:02:45,120
Speaker 2: that we have brought. It's effectiveate management solution. And also

56
00:02:45,280 --> 00:02:49,360
Speaker 2: it's not just that it's also recommended to be used

57
00:02:49,360 --> 00:02:55,160
Speaker 2: together with their lifestyle change reduced colorI diet and exercise

58
00:02:55,240 --> 00:02:59,079
Speaker 2: as well. When we talk about diabetic patients, then diabetic

59
00:02:59,120 --> 00:03:02,680
Speaker 2: patients have film products that they should be using for treatment.

60
00:03:03,000 --> 00:03:05,440
Speaker 1: All right, Anna, thank you very much, really appreciate your time.

61
00:03:05,440 --> 00:03:08,640
Speaker 1: It's doctor Arna Spenson, who's the vice president Medical Oceania

62
00:03:08,720 --> 00:03:12,880
Speaker 1: Novo Nordisk. For more from Hither Duplessy Allen Drive, listen

63
00:03:12,960 --> 00:03:16,000
Speaker 1: live to news talks. It'd be from four pm weekdays,

64
00:03:16,120 --> 00:03:18,320
Speaker 1: or follow the podcast on iHeartRadio